• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者肾血流的重新分布。肾前列腺素E2的作用。

Redistribution of renal blood flow in patients with liver cirrhosis. The role of renal PGE2.

作者信息

Sacerdoti D, Merlo A, Merkel C, Zuin R, Gatta A

出版信息

J Hepatol. 1986;2(2):253-61. doi: 10.1016/s0168-8278(86)80084-8.

DOI:10.1016/s0168-8278(86)80084-8
PMID:3457085
Abstract

Cirrhotic patients frequently show a decrease in renal blood flow and redistribution of the flow from the outer cortex to the juxtamedullary cortex. The cause of the maintenance of juxtamedullary perfusion is not presently known. Prostaglandin E2 (PGE2) has its vasodilating effect on medullary and juxtamedullary vessels where it is synthesized. Therefore, its increased production, frequently shown in cirrhotics, could be responsible for the relative preservation of juxtamedullary blood flow. To verify this hypothesis we examined 13 cirrhotic patients. In these patients we determined mean renal blood flow (MRBF), blood flow in the 1st compartment (ICBF) and in the 2nd compartment (IICBF) with the 133-Xenon washout technique and PGE2 plasma levels in the renal veins (PGE2V). MRBF and ICBF were significantly reduced as compared to control subjects (P less than 0.01); IICBF resulted unaltered. Significant correlation was found between IICBF and PGE2V (P less than 0.01). Our data confirm the decrease in renal blood flow and the redistribution of intrarenal blood flow in cirrhotic patients. The maintenance of IICBF is likely to be a consequence of PGE2 renal production.

摘要

肝硬化患者常出现肾血流量减少,血流从肾外皮质重新分布至近髓质皮质。目前尚不清楚维持近髓质灌注的原因。前列腺素E2(PGE2)对其合成部位的髓质和近髓质血管具有血管舒张作用。因此,肝硬化患者中常见的PGE2产量增加,可能是近髓质血流相对得以保留的原因。为验证这一假设,我们检查了13例肝硬化患者。我们用133-氙洗脱技术测定了这些患者的平均肾血流量(MRBF)、第一部分肾血流量(ICBF)和第二部分肾血流量(IICBF),并测定了肾静脉中的PGE2血浆水平(PGE2V)。与对照组相比,MRBF和ICBF显著降低(P<0.01);IICBF未发生改变。IICBF与PGE2V之间存在显著相关性(P<0.01)。我们的数据证实了肝硬化患者肾血流量减少及肾内血流重新分布。IICBF得以维持可能是肾产生PGE2的结果。

相似文献

1
Redistribution of renal blood flow in patients with liver cirrhosis. The role of renal PGE2.肝硬化患者肾血流的重新分布。肾前列腺素E2的作用。
J Hepatol. 1986;2(2):253-61. doi: 10.1016/s0168-8278(86)80084-8.
2
Renal and intrarenal blood flow in non-cirrhotic portal hypertension.非肝硬化性门静脉高压症中的肾内及肾血流情况
Gut. 1972 Oct;13(10):763-7. doi: 10.1136/gut.13.10.763.
3
Intrarenal blood flow, circulation time, and cortical vascular volume in patients with cirrhosis.肝硬化患者的肾内血流、循环时间和皮质血管容积
Scand J Gastroenterol. 1981;16(6):775-80. doi: 10.3109/00365528109181003.
4
Urinary prostaglandins and renal function in chronic liver diseases.慢性肝病中的尿前列腺素与肾功能
Scand J Gastroenterol. 1986 Jan;21(1):75-81. doi: 10.3109/00365528609034626.
5
Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome).肝硬化腹水患者6-酮-前列腺素F1α、血栓素B2和前列腺素E2的尿排泄。与功能性肾衰竭(肝肾综合征)的关系。
J Hepatol. 1986;3(1):111-7. doi: 10.1016/s0168-8278(86)80154-4.
6
Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.增强型体外反搏:一种改善肝硬化患者肾功能的新技术。
Nephrol Dial Transplant. 2005 May;20(5):920-6. doi: 10.1093/ndt/gfh755. Epub 2005 Mar 23.
7
Enhanced renal sympathetic tone in liver cirrhosis: evaluation by intrarenal administration of dihydroergocristine.肝硬化患者肾交感神经张力增强:通过肾内注射双氢麦角汀进行评估。
Nephron. 1982;30(4):364-7. doi: 10.1159/000182519.
8
Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis.普萘洛尔对肝硬化患者服用呋塞米后尿前列腺素E2排泄及肾叶间动脉血流的影响。
Eur J Clin Pharmacol. 1992;43(5):555-8. doi: 10.1007/BF02285102.
9
Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis.
Kidney Int. 1984 Jul;26(1):72-80. doi: 10.1038/ki.1984.136.
10
Functional renal alterations in chronic liver diseases.慢性肝病中的功能性肾脏改变
Digestion. 1980;20(2):73-8. doi: 10.1159/000198421.

引用本文的文献

1
Hepatorenal syndrome: Current concepts and future perspectives.肝肾综合征:当前概念与未来展望。
Clin Mol Hepatol. 2023 Oct;29(4):891-908. doi: 10.3350/cmh.2023.0024. Epub 2023 Apr 13.
2
Metamizole-Associated Risks in Decompensated Hepatic Cirrhosis.扑热息痛相关风险在肝功能失代偿期肝硬化。
Dtsch Arztebl Int. 2022 Oct 14;119(41):687-693. doi: 10.3238/arztebl.m2022.0280.
3
Role of the cytochrome P-450/ epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis.细胞色素 P-450/环氧二十碳三烯酸途径在肝硬化肾功能障碍发病机制中的作用。
Nephrol Dial Transplant. 2018 Aug 1;33(8):1333-1343. doi: 10.1093/ndt/gfx354.
4
Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE.肝硬化患者的类二十烷酸排泄。20-羟基二十碳四烯酸占主导地位。
J Clin Invest. 1997 Sep 1;100(5):1264-70. doi: 10.1172/JCI119640.
5
Renal effects of nadolol in cirrhosis.
Eur J Clin Pharmacol. 1987;33(5):473-7. doi: 10.1007/BF00544238.